Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer

Cancer Treat Rep. 1984 May;68(5):803-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Drug Evaluation
  • Female
  • Humans
  • Immune Tolerance / drug effects
  • Infusions, Parenteral
  • Middle Aged
  • Vinblastine / administration & dosage*
  • Vinblastine / adverse effects

Substances

  • Vinblastine